GlassScriptPhysician profile
John Santa Ana
NPI 1285783225
$6,166.22
in general payments reported to CMS, 2019-2025
31 companies · $632 in 2025
The $632 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2021: $386 · 2022: $2,870 · 2023: $507 · 2024: $488 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,539.31 | 2019-2023 | |
| Nevro Corp. | $713.27 | 2019-2024 | Senza |
| Boston Scientific Corporation | $318.51 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $310.78 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Saluda Medical Americas, INC. | $251.72 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $196.81 | 2022-2025 | Proclaim |
| Globus Medical, INC. | $155.20 | 2025 | Senza |
| Spr Therapeutics, INC | $133.03 | 2021-2025 | Sprint Pns System |
| Genzyme Corporation | $64.53 | 2019 | |
| Bioventus LLC | $46.71 | 2019-2022 | |
| Stimwave Technologies Incorporated | $46.02 | 2022 | |
| Vertical Pharmaceuticals, LLC | $40.61 | 2019 | |
| Mdd US Operations, LLC | $31.46 | 2019 | |
| Merz North America, INC. | $30.99 | 2019 | |
| Si-Bone, INC. | $26.01 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25.34 | 2019 | |
| Spinal Simplicity, LLC | $25.16 | 2025 | Ha Minuteman G3-R |
| Alnylam Pharmaceuticals INC. | $22.75 | 2019 | |
| Abbvie INC. | $20.71 | 2025 | |
| Siemens Medical Solutions USA, INC. | $17.69 | 2025 | Cios Flow |
| Biodelivery Sciences International, INC. | $17.59 | 2019 | |
| Nalu Medical, INC. | $16.72 | 2023 | Nalu Neurostimulation System |
| Amgen INC. | $15.14 | 2019 | |
| Grt US Holding, INC. | $14.21 | 2021 | |
| Depuy Synthes Sales INC. | $14.01 | 2021 | |
| Lilly USA, LLC | $13.55 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $12.69 | 2021 | |
| Kaleo, INC. | $11.84 | 2019 | |
| Lundbeck LLC | $11.78 | 2019 | |
| Pfizer INC. | $11.29 | 2019 | |
| Stryker Corporation | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Santa Ana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.